Transforming psoriasis treatment biological preparation can increase the response rate to 80%
Psoriasis, commonly known as “psoriasis”. In fact, silver psoriasis is not the “psoriasis” in our impression, because it is not a simple skin disease. Psoriasis is a systemic disease. It is not only manifested on the skin, but also infringes on the skin accessories other than the skin, including hair and nails, forming psoria nails and psorians. In addition, psoriasis will also be accompanied by other diseases, affecting the quality of life of patients. For example, arthritis (psoriasis arthritis) may cause patients to be unable to walk, unable to live and study normally. The accompanying cardiovascular disease, diabetes, hypertension, and metabolic syndrome will also affect the health of patients to a certain extent.
At present, there are about 6.5 million psoriasis patients in China. There are four main categories of psoriasis: skin medications, physical therapy, systematic treatment, and biological preparations. With the development of the basic research of psoriasis, the use of biological agents has achieved good results, which can increase the response rate to 75%-80%.
In recent years, biological preparations have been approved by the State Drug Administration for treatment for psoriasis systems.
In May 2017, the State Administration of Food and Drug Administration of China approved the Merido (Ada Mu Ming Reta) to be used for systematic treatment or phototherapy, and Optic chemotherapy) Patients with no sensitivity, or contraindicated, or tolerated adult medium -weight chronic plaques psoriasis.
<!-2528: Dermatology terminal page
In 2018, the State Drug Administration approved the change of drugs for Xiu Meile from clinical second -line system to the treatment of clinical first -line system treatment, which will provide more treatment options for more Chinese psoriasis patients in the early treatment stage.
With the increase of society’s attention to psoriasis, the treatment of psoriasis is no longer difficult. It is reported that biological preparations in some areas have begun to be included in the medical insurance of major illnesses, and there are also many public welfare projects in the society who are in need of psoria patients. For example, the “Holding Tomorrow” public welfare donation project hosted and organized by the China Junior Health Care Foundation. Low), sharing some treatment costs for patients, reduce economic burden, and help patients gradually establish a standardized treatment concept, improve treatment compliance, and achieve better treatment results.
October 29th is World Psoriasis Day. All sectors of society call on people to correctly understand psoriasis and face up to patients with psoriasis. Patients with psoriasis should pay attention to and respect. With the development of advanced drugs such as biological preparations and the popularity in China, more treatment methods will be used in psoriasis in the future, and the quality of life of patients will continue to improve.
